I agree that navigating ISO 10993’s biocompatibility requirements poses significant challenges, especially when dealing with complex materials and rapidly evolving medical technologies like nanomaterials and bioresorbables. In addition to the financial and time constraints mentioned, another hurdle is the global…   Read more»